Surfactant and continuous positive airway pressure for the prevention of chronic lung disease: History, reality, and new challenges

• Published in: Seminars in fetal & neonatal medicine 2017-10, Vol.22 (5), p.348-353
• Main Authors: Aly, Hany, Mohamed, Mohamed A., Wung, Jen-Tien
• Format: Article
• Language: English
• Subjects: Bronchopulmonary dysplasia; Bubble continuous positive airway pressure (CPAP); Chronic Disease - prevention & control; Continuous Positive Airway Pressure - methods; Female; Humans; Hyaline membrane disease; Infant, Newborn; Intubation; Less-invasive surfactant; Lung Diseases - prevention & control; Pregnancy; Pulmonary Surfactants - therapeutic use; Respiratory distress syndrome; Respiratory Distress Syndrome, Newborn - therapy
• ISSN: 1744-165X; 1878-0946
• DOI: 10.1016/j.siny.2017.08.001

The discovery of surfactant was one of the most significant research events to occur in the history of neonatology. Certainly, surfactant saved lives for premature infants who were otherwise considered non-viable. However, the prevention of chronic lung disease did not progress and it became clear that a significant portion of the help surfactant provides to the premature lung is counteracted by mechanical ventilation. A dilemma exists over the priorities in premature management to intubate and administer surfactant or not to intubate and support these infants non-invasively with the use of continuous positive airway pressure. A new hydrophilic surfactant preparation has been developed with the hope to enable the introduction of surfactant therapy without the need for tracheal intubation. Clinical trials on this product are currently in progress. This article provides the history and prospect of respiratory distress management in premature infants and evaluates the current evidence for non-invasive practices.